Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma

Cancer

Volumn 91, Issue 11, 2001, Pages 2071-2076

  De Crevoisier, Renaud ^a   Domenge, Christian ^a   Wibault, Pierre ^a   Koscielny, Serge ^a   Lusinchi, Antoine ^a   Janot, François ^a   Bobin, Serge ^b   Luboinski, Bernard ^a   Eschwege, François ^a   Bourhis, Jean ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Postoperative radiotherapy; Reirradiation; Salvage surgery; Squamous cell carcinoma of the head and neck

Indexed keywords

FLUOROURACIL; HYDROXYUREA;

ADULT; AGED; ARTICLE; BONE NECROSIS; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROSIS; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE METASTASIS; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RADIATION DOSE; SALVAGE THERAPY; SECOND CANCER; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; HYDROXYUREA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; RISK FACTORS; SALVAGE THERAPY; SURVIVAL ANALYSIS;

EID: 0035371434     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010601)91:11<2071::AID-CNCR1234>3.0.CO;2-Z     Document Type: Article

References (48)

1. De Crevoisier R, Bourhis J, Domenge C, Wibault P, Koscielny S, Lusinchi A, et al. Full-dose re-irradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 1998;16:3556-62.
2. Haraf D, Weichselbaum R, Vokes E. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. Ann Oncol 1996; 7:913-8.
3. Ridge J. Squamous cancer of head and neck: surgical treatment of local and regional recurrence. Semin Oncol 1993; 20:419-29.
4. Williams R. Recurrent head and neck cancer: the results of treatment. Br J Surg 1974;61:691-7.
5. Looser K, Shah J, Strong E. The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg 1978;1:107-11.
6. Byers R, Bland K, Borlase B, Luna M. The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck. Am J Surg 1978;136:525-8.
7. Jacobs J, Ahmad K, Casiano R, Schuller DE, Scott C, Laramore GE, et al. Implications of positive surgical margins. Laryngoscope 1993;103:64-8.
8. Shah J, Cendon R, Farr H, Strong E. Carcinoma of the oral cavity: factors affecting treatment failure at the primary site and neck. Am J Surg 1976;132:504-7.
9. Johnson J, Barnes E, Myers E, Schramm V, Borochowitz D, Sigler B. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 1981;107:725-9.
10. Arriagada R, Eschwège F, Cachin Y, Richard J. The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers. Cancer 1983;51:1819-25.
11. Cachin Y, Eschwege F. Combination of radiotherapy and surgery in the treatment of head and neck cancer. Cancer Treat Rep 1975;2:177-91.
12. Feldman M, Fletcher G. Analysis of the parameters relating to failures above the clavicles in patients treated by postoperative irradiation for squamous cell carcinoma of the oral cavity or oropharynx. Int J Radiat Oncol Biol Phys 1982;8: 27-30.
13. Kramer A, Gelber R, Snow JB, Marcial VA, Lowry LD, Davis LW, et al. Combined radiation therapy and surgery in the management of head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987;10:19-30.
14. Vikram B, Strong E, Shah J, Spiro R. Failure at the primary site following mutimodality treatment in advanced head and neck cancer. Head Neck Surg 1984;6:720-3.
15. Bartelink H, Breur K, Hart G, Annyas B, Glooten E, Snow G. The value of postoperative radiotherapy as an adjuvant to radical neck dissection. Cancer 1983;52:1003-8.
16. Vokes E, Panje WR, Schilsky RL, Mick R, Awan AM, Moran WJ, et al. Hydroxyurea, fluorouracil and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study. J Clin Oncol 1989;7:761-8.
17. Vokes E, Panje W, Weichselbaum R, Schilsky RL, Moran WJ, Awan AM, et al. Concomitant hydroxyurea, 5-fluorouracil and radiation therapy for recurrent head and neck cancer: early results. Otolaryngol Head Neck Surg 1988;98:295-8.
18. Haraf D, Vokes E, Panje W, Weichselbaum R. Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer. Am J Clin Oncol 1991;14:419-26.
19. Gandia D, Wibault P, Guillot T, Bensmaine A, Armand JP, Marandas P, et al. Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer. Head and Neck 1993;15:8-15.
20. International Commission on Radiation Units and Measurement. Prescribing, recording and reporting photon beam therapy. International Commission on Radiological Units report no. 50, 1993.
21. Peters L, Goepfert H, Ang K, Byers RM, Maor MH, Guillamondegui O, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer : first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993;26:3-11.
22. Bourhis J, Pignon J, Désigné L, Luboinski M, Guérin S, Domenge C. Meta-analysis of chemotherapy in head and neck cancer: loco-regional treatment vs same treatment + chemotherapy. Proc ASCO 1998;17:1486.
23. Hong W, Bromer R. Chemotherapy in head and neck cancer. N Engl J Med 1983;308:75-9.
24. Richard G, Chambers R. Hydroxyurea and radiotherapy in head and neck cancer. Radiology 1971;101:391-6.
25. Byfield J, Calabro-Jones P, Klisak J, Kulhamix F. Pharmacologic requirements for attaining sensitization of human tumor cells in vitro to combined 5-fluorouracil of ftorafur and X-rays. Int J Radiat Oncol Biol Phys 1982;8:1923-33.
26. Frankfurt O. Enhancement of the antitumor activity of 5-fluorouracil by dry combinations. Cancer Res 1973;33:1043-7.
27. Fu K, Newman H, Phillips T. Treatment of locally recurrent carcinoma of the nasopharynx. Radiology 1975;117:425-31.
28. Haraf D, Vokes E, Weichselbaum R, Panje W. Concomitant chemoradiotherapy with cisplatin, 5-fluoruracil and hydroxyurea in poor prognostic head and neck cancer. Laryngoscope 1992;102:630-6.
29. McNeese M, Fletcher G. Retreatment of recurrent nasopharyngeal carcinoma. Radiology 1981;138:191-3.
30. Wang C. Re-irradiation of recurrent nasopharyngeal carcinoma - treatment technique and results. Int J Radiat Oncol Biol Phys 1987;13:953-6.
31. Langlois D, Eschwège F, Kramar A, Richard J. Re-irradiation of head and neck cancers. Presentation of 35 cases treated at the Gustave Roussy Institute. Radiother Oncol 1985;3:27-33.
32. Tercilla O, Schmidt-Ullrich R, Wazer D. Re-irradiation of head and neck neoplasms using twice-a-day scheduling. Strahlenther Onkol 1993;169:285-90.
33. Pomp J, Levendag P, van Putten W. Re-irradiation of recurrent tumors in the head and neck. Am J Clin Oncol 1988;11: 543-9.
34. Levendag P, Meeuwis C, Visser A. Re-irradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy. Radiother Oncol 1992;23:6-15.
35. Stevens JR, Britsch A, Moss W. High-dose re-irradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 1994;29:687-98.
36. Yan J, Hu Y, Gu X. Radiation therapy of recurrent nasopharyngeal carcinoma. Report of 219 patients. Acta Radiol Oncol 1983;22:23-8.
37. Slolyszewski J, Korzeniowski S, Reinfuss M. The re-irradiation of recurrences of head and neck cancer. Br J Radiol 1980;53:462-5.
38. Orecchia R, Airoldi M, Sola B, Ragona R, Bussi M, Bongioannini, et al. Results of chemotherapy plus external re-irradiation in the treatment of locally advanced recurrences of nasopharyngeal carcinoma. Eur J Cancer Oral Oncol 1992; 28B:109-11.
39. Weppelmann B, Wheeler R, Peters G, Kim RY, Spencer SA, Meredith RF, et al. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and re-irradiation. Int J Radiat Oncol Biol Phys 1992;22:1051-6.
40. Emami B, Bignardi M, Spector GJ, Devineni VR, Hederman MA. Re-irradiation of recurrent head and neck cancers. Laryngoscope 1987;97:85-8.
41. Lee A, Law S, Foo W, Poon YF, Cheung FK, Chan DK, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-85: survival after local recurrence. Int J Radiat Oncol Biol Phys 1993;26:773-82.
42. Pryzant M, Wendt C, Declos L, Peters L. Re-treatment of nasopharyngeal carcinoma in 53 patients. Int J Radiat Oncol Biol Phys 1992;29:687-98.
43. Brockstein B, Haraf D, Stenson K, Fasanmade A, Stupp R, Glisson B, et al. Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck. J Clin Oncol 1998;16:735-44.
44. Spencer S, Wheeler R, Peters G, Beenken SW, Meredith RF, Smith J, et al. Concomitant chemotherapy and re-irradiation as management for recurrent cancer of the head and neck. Am J Clin Oncol 1999;22:1-5.
45. Hwang J, Fu K, Phillips T. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1998;41:1099-111.
46. Teo P, Kwan W, Chan W, On Mok C. How successful is high-dose re-irradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 1998;40:897-913.
47. Benchalal M, Bachaud JM, Francois P, Alzieu C, Giraud P. David JM, et al. Hyperfractionation in the re-irradiation of head and neck cancers. Result of a pilot study. Radiother Oncol 1995;36:203-10.
48. Wang C, McIntyre J. Re-irradiation of laryngeal carcinoma. Techniques and results. Int J Radiat Oncol Biol Phys 1993;26:783-5.